Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
Mayo Clinic
City of Hope Medical Center
University of California, Davis
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
NRG Oncology
Mayo Clinic
University of Maryland, Baltimore
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Jiangsu Cancer Institute & Hospital
NRG Oncology
NRG Oncology
China Medical University, China
Centre Antoine Lacassagne
NRG Oncology
Dana-Farber Cancer Institute
Mayo Clinic
Uganda Cancer Institute
Mayo Clinic
Jonsson Comprehensive Cancer Center
University of Southern California
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
Peking Union Medical College
Lund University Hospital
Trans Tasman Radiation Oncology Group
Sun Yat-sen University
University of Michigan Rogel Cancer Center
Shanghai Pulmonary Hospital, Shanghai, China
Emory University
Shanghai Junshi Bioscience Co., Ltd.
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
China Medical University, China
Women's Hospital School Of Medicine Zhejiang University
M.D. Anderson Cancer Center
Mayo Clinic
NRG Oncology
Ohio State University Comprehensive Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
UNICANCER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences